| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Revenue | $292.5M | -3.8% |
| Cost of Revenue | $134.8M | -9.7% |
| Gross Profit | $157.7M | +1.9% |
| R&D Expense | $26.2M | -16.8% |
| SG&A Expense | $42.1M | +2.3% |
| Operating Income | -$40.0M | +79.2% |
| Pre-tax Income | -$34.0M | +82.2% |
| Income Tax | -$39K | +99.5% |
| Net Income | -$34.0M |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.9M | -26.5% |
| Accounts Receivable | $42.9M | -1.7% |
| Inventory | $62.0M | +2.3% |
| Current Assets | $168.3M | -12.9% |
| Total Assets | $280.1M | -11.8% |
| Current Liabilities | $76.2M | -16.4% |
| Total Liabilities | $97.2M | -13.3% |
| Line Item | 2025-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | +64.0% |
| Capital Expenditures | $4.5M | +77.3% |
| Investing Cash Flow | -$10.2M | -108.2% |
| Financing Cash Flow | -$255K | +99.6% |
| Free Cash Flow | -$14.6M | +52.4% |
| +81.6% |
| EPS (Basic) | -$0.83 | +81.9% |
| EPS (Diluted) | -$0.83 | +81.9% |
| Stockholders' Equity |
| $183.0M |
| -11.0% |